ACE and myocardial infarction: The Heart Outcome Prevention Evaluation (HOPE) study assessed the effects of angiotensin-converting enzyme (ACE) inhibition and vitamin E on incident cardiovascular disease (CV death, stroke, and non-fatal myocardial infarction (MI)) [14].